Eupalinilide B is a naturally occurring cyclic peptide originally isolated from the marine sponge, Hyrtios erectus. It possesses a unique structure and is recognized as a potent inhibitor of the proteasome, a cellular system responsible for protein degradation. Eupalinilide B has garnered attention for its potential anti-cancer properties, including the induction of apoptosis in cancer cells, and has demonstrated activity against a range of cancer cell lines, positioning it as a promising candidate for further research and drug development in oncology.
757202-08-7
Post Buying Request-
-
Basic information
- Product Name: Eupalinilide B
- Synonyms: Eupalinilide B
- CAS NO:757202-08-7
- Molecular Formula: C20H24O6
- Molecular Weight: 360.4
- EINECS: N/A
- Product Categories: chemical reagent;pharmaceutical intermediate;phytochemical;reference standards from Chinese medicinal herbs (TCM).;standardized herbal extract;Sesquiterpenoids
-
Chemical Properties
- Melting Point: N/A
- Boiling Point: 571.2±50.0 °C(Predicted)
- Flash Point: N/A
- Appearance: /
- Density: 1.27±0.1 g/cm3 (20 ºC 760 Torr)
- Refractive Index: N/A
- Storage Temp.: N/A
- Solubility: N/A
- PKA: 13.56±0.40(Predicted)
- CAS DataBase Reference: Eupalinilide B(CAS DataBase Reference)
- NIST Chemistry Reference: Eupalinilide B(757202-08-7)
- EPA Substance Registry System: Eupalinilide B(757202-08-7)
-
Safety Data
- Hazard Codes: N/A
- Statements: N/A
- Safety Statements: N/A
- WGK Germany:
- RTECS:
- HazardClass: N/A
- PackingGroup: N/A
- Hazardous Substances Data: 757202-08-7(Hazardous Substances Data)
757202-08-7 Suppliers
Recommended suppliers
757202-08-7 Usage
Uses
Used in Pharmaceutical Industry:Eupalinilide B is used as a lead compound in drug discovery and development for its potential anti-cancer properties. Its unique structure and activity as a proteasome inhibitor make it a valuable asset in the search for novel cancer treatments.
Used in Oncology Research:
Eupalinilide B is utilized as a research tool to study the mechanisms of apoptosis induction in cancer cells. Its effectiveness against various cancer cell lines aids in understanding the broader implications of proteasome inhibition in cancer therapy.
Used in Cancer Treatment Development:
Eupalinilide B is explored as a potential drug candidate for the treatment of cancer, given its ability to induce programmed cell death in cancer cells and its demonstrated activity against multiple cancer types. Further research is necessary to harness its potential in clinical applications.
Check Digit Verification of cas no
The CAS Registry Mumber 757202-08-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,5,7,2,0 and 2 respectively; the second part has 2 digits, 0 and 8 respectively.Calculate Digit Verification of CAS Registry Number 757202-08:
(8*7)+(7*5)+(6*7)+(5*2)+(4*0)+(3*2)+(2*0)+(1*8)=157
157 % 10 = 7
So 757202-08-7 is a valid CAS Registry Number.
757202-08-7Upstream product
757202-08-7Downstream Products
Post a RFQ
1
What can I do for you?
Get Best Price
Get Best Price for 757202-08-7
Eupalinilide B
